Chester County News and Community Website
WILMINGTON, DE — Quavo, Inc. said disputes tied to Spirit Airlines transactions surged roughly 1,000% in the 72 hours following the airline’s May 2 shutdown, highlighting growing operational and compliance …
Spirit Shutdown Triggers Surge in Airline Chargebacks, Quavo Says Read More
WILMINGTON, DE — Ashland Inc. (NYSE: ASH) increased its quarterly cash dividend by 1.2% to $0.42 per share, continuing a series of shareholder payouts as the specialty materials company operates …
Ashland Raises Quarterly Dividend 1.2% for Shareholders Read More
WILMINGTON, DE — Global Indemnity Group (Nasdaq: GBLI) reported first-quarter profit after wildfire-related losses weighed on results a year earlier, while underwriting performance remained stable despite softer premium growth in …
Global Indemnity Returns to Profit After Wildfire Losses Read More
WILMINGTON, DE — NRx Pharmaceuticals (Nasdaq: NRXP) has placed its first commercial manufacturing order for a preservative-free ketamine product ahead of a potential U.S. approval expected under the Generic Drug …
NRx Begins Ketamine Production Ahead of FDA Decision Read More
WILMINGTON, DE — Admaxxer, a direct-to-consumer advertising analytics startup, said more than 5,000 brands now use its platform as e-commerce marketers increasingly seek first-party data and AI-driven ad tools following …
Admaxxer Tops 5,000 Brands Amid AI Ad-Tech Expansion Read More
WILMINGTON, DE — Incyte (Nasdaq: INCY) recently received U.S. Food and Drug Administration approval for Jakafi XR, a once-daily extended-release version of ruxolitinib, giving patients with several chronic blood disorders …
FDA Approves Once-Daily Jakafi XR for Blood Disorders Read More
WILMINGTON, DE — Phreesia, Inc. (NYSE: PHR) announced it will release fiscal first-quarter 2027 financial results after markets close on May 27, followed by a conference call with investors and …
Phreesia Sets May 27 Date for Quarterly Results Read More
WILMINGTON, DE — An advisory committee to the U.S. Food and Drug Administration voted 7-1, with one abstention, that AstraZeneca’s TRUQAP combination therapy demonstrated a favorable benefit-risk profile for patients …
FDA Panel Backs AstraZeneca Prostate Cancer Drug Combo Read More
WILMINGTON, DE — Diversified, LLC, a leading fee-only registered investment advisor, today announced the appointment of Scott Lavelle, CFA, CAIA, FRM as Chief Investment Officer, effective May 11, 2025. Lavelle …
Diversified Appoints Scott Lavelle as Chief Investment Officer Read More
WILMINGTON, DE — ChristianaCare recently submitted a Notice of Intent to Delaware regulators for a new health campus in Camden that would include a neighborhood hospital and outpatient care center …
ChristianaCare Plans Camden Hospital as Delaware Demand Grows Read More